Lilly Bounces Into ‘Sell in May’ Territory Amid Pricing Pressure
Eli Lilly posts above-consensus Q1 results, lifting shares yet leaving the year-to-date narrative pressured by pricin...
Poor planning undermines budget success; explore effective forecasting, set realistic goals, and implement steady review to keep your finances on course.
21,840 articlesEli Lilly posts above-consensus Q1 results, lifting shares yet leaving the year-to-date narrative pressured by pricin...
As Uber eyes profitability, a multi-year bull case hinges on margin expansion and stronger bookings. This analysis ou...
Circle’s ARC presale unlocks a $3 billion fully diluted valuation and signals a broader push into institutional finan...
PEY sits at a crossroads, pairing long-running dividend growers with higher-yielding, potentially riskier payors. As ...
Binance’s delisting of five smaller tokens sparked a brutal price collapse altcoins, with double-digit losses across ...
In today’s market, winning listings today’s market hinge on coaching and lender-led planning rather than traditional ...
Stellantis stands at a defining juncture. A strategic call on brand focus and EV spending could reshape profitability...
The T3 Financial Crime Unit, supported by tether, tron labs-backed financial partners, says it has frozen over $450 m...
Regulatory pressure around UnitedHealth shifts attention to two defensible, cash-generating stocks with strong divide...
Satellogic’s 2026 earnings hinge on a mix of recurring data licenses, expanding contracts, and efficient scaling. Thi...
In May 2026, a century-old California dairy finds new life through AI agents and direct-to-consumer strategies, turni...
New to prediction markets? This friendly guide shows you how to get started with Myriad, fund your account, and start...